The global synthetic biology market is growing, due to increasing support from government organizations, and growing geriatric population. In addition, the innovative and advanced applications of synthetic biology, increasing research activities, and increasing R&D investments in drug discovery and development are also supporting the growth of this market.

[b]Explore More About “Global Synthetic Biology Market” at:[/b] https://www.psmarketresearch.com/market-analysis/synthetic-biology-market

On the basis of type of segment, the technology segment is expected to be the largest market and would witness fastest growth during the forecast period. Among the application segment, pharmaceutical and diagnostic had the largest market size in the global market in 2014.

[b]Browse Related Research:[/b] https://www.psmarketresearch.com/industry-report/healthcare

The increasing support from government organizations and growing geriatric population are playing a pivotal role in the growth of this market. Some of the major organizations include National Science Foundation (NSF), National Aeronautics and Space Administration (NASA), Centre for Chemical and Synthetic Biology (CCSB), Synthetic Biology Engineering Research Center (SynBERC), and International Association Synthetic Biology (IASB). These organizations are providing support in form of funding, and initiatives implemented by them for basic and applied research with their respective goals.

Additionally, the innovative and advanced applications of synthetic biology, increasing research activities, and increasing R&D investments in drug discovery and development are also supporting the growth of this market. However stringent regulatory requirements, expensive research procedures, and harmful effects of synthetic biology act as hindrance in the growth of the global market. The growing number of mergers and acquisitions is one of the latest trends observed in this market.

The key companies operating in the global synthetic biology market include E. I. du PONT de Nemours and Company, Amyris Inc., GenScript USA Inc., Intrexon Corporation, Thermo Fisher Scientific Inc., Synthetic Genomics Inc., Royal DSM, Novozymes A/S, New England Biolabs Inc., and Integrated DNA Technologies Inc.

[b]SYNTHETIC BIOLOGY MARKET SEGMENTATION[/b]

Breakdown by Segment
 Technology

o Enabled Technology
 Gene Synthesis
 Bioinformatics
 Genome Engineering
 Cloning
 Mutagenesis
 Gene Measurement and Modeling
 Microfluidics

o Enabling Technology
 Pathway Engineering
 Next Generation Sequencing
 Tool
 Oligonucleotide
 Cloning Kit
 Enzyme
 Xeno Nucleic Acid
 Chassis Organisms

Breakdown by Application
 Pharmaceutical and R&D
 Chemical
 Energy
 Agriculture

Breakdown by Geography
 North America - The U.S., Canada, and Rest of North America
 Europe - the U.K., Germany, France, Italy, Spain, and Rest of Europe
 Asia - China, Japan, India, and Rest of Asia
 Rest of the World (RoW)

[b]About P&S Market Research[/b]

P&S Market Research is a market research company, which offers market research and consulting services for various geographies around the globe. We provide market research reports, industry forecasting reports, business intelligence, and research based consulting services across different industry/business verticals.

As one of the top growing market research agency, we’re keen upon providing market landscape and accurate forecasting. Our analysts and consultants are proficient with business intelligence and market analysis, through their interaction with leading companies of the concerned domain. We help our clients with B2B market research and assist them in identifying various windows of opportunity, and framing informed and customized business expansion strategies in different regions.

[b]Contact:[/b]
Deep
Assistant – Client Partner
347, 5th Ave. #1402
New York City, NY - 10016
Toll-free: +1-888-778-7886 (USA/Canada)
Email: [email protected]
Web: https://www.psmarketresearch.com